AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION
Authors: RATANATHARATHORN V NASH RA PRZEPIORKA D DEVINE SM KLEIN JL WEISDORF D FAY JW NADEMANEE A ANTIN JH CHRISTIANSEN NP VANDERJAGT R HERZIG RH LITZOW MR WOLFF SN LONGO WL PETERSEN FB KARANES C AVALOS B STORB R BUELL DN MAHER RM FITZSIMMONS WE WINGARD JR
Citation: V. Ratanatharathorn et al., PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Blood, 92(7), 1998, pp. 2303-2314
A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: BERNSTEIN SH NADEMANEE AP VOSE JM TRICOT G FAY JW NEGRIN RS DIPERSIO J RONDON G CHAMPLIN R BARNETT MJ CORNETTA K HERZIG GP VAUGHAN W GEILS G KEATING J MESSNER H WOLFF SN MILLER KB LINKER C CAIRO M HELLMANN S ASHBY M STRYKER S NASH RA
Citation: Sh. Bernstein et al., A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3509-3517
THE USE OF CONVENTIONAL SALVAGE CHEMOTHERAPY BEFORE DOSE-INTENSIVE CYTOTOXIC THERAPY AND AUTOLOGOUS TRANSPLANTATION FOR AGGRESSIVE-HISTOLOGY LYMPHOMA - A CASE FOR REEVALUATION
Authors: PHILLIPS GL REECE DE WOLFF SN GOLDIE JH
Citation: Gl. Phillips et al., THE USE OF CONVENTIONAL SALVAGE CHEMOTHERAPY BEFORE DOSE-INTENSIVE CYTOTOXIC THERAPY AND AUTOLOGOUS TRANSPLANTATION FOR AGGRESSIVE-HISTOLOGY LYMPHOMA - A CASE FOR REEVALUATION, Leukemia & lymphoma, 26(5-6), 1997, pp. 507-513
DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: COLLINS RH SHPILBERG O DROBYSKI WR PORTER DL GIRALT S CHAMPLIN R GOODMAN SA WOLFF SN HU W VERFAILLIE C LIST A DALTON W OGNOSKIE N CHETRIT A ANTIN JH NEMUNAITIS J
Citation: Rh. Collins et al., DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 15(2), 1997, pp. 433-444
LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - UPDATED RESULTS FROM 2 TRIALS EVALUATING POSTINDUCTION CHEMOTHERAPY
Authors: BLOOMFIELD CD HERZIG GP PETERSON BA WOLFF SN
Citation: Cd. Bloomfield et al., LONG-TERM SURVIVAL OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA - UPDATED RESULTS FROM 2 TRIALS EVALUATING POSTINDUCTION CHEMOTHERAPY, Cancer, 80(11), 1997, pp. 2186-2190
AUTOLOGOUS STEM-CELL IN-VITRO PURGING WITH W16 MEDROL IN PATIENTS WITH MINIMAL BM INVOLVEMENT/
Authors: AHMED MS WOLFF SN GREER JP PRICE JO STEIN RS KALLIANPUR AR BRANDT SJ PRATER K GOODMAN SA
Citation: Ms. Ahmed et al., AUTOLOGOUS STEM-CELL IN-VITRO PURGING WITH W16 MEDROL IN PATIENTS WITH MINIMAL BM INVOLVEMENT/, Blood, 90(10), 1997, pp. 4545-4545
MEGA-THERAPY FOR HIGH-RISK AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) - THE VANDERBILT EXPERIENCE WITH HIGH-DOSE, BRIEF-DURATION CHEMOTHERAPY
Authors: ARROWSMITH ER MACON WR WOLFF SN JOHNSON DH STEIN RS FLEXNER JM GOODMAN SA HANDE KR KALLIANPUR A JOHNSON DR SHYR Y GREER JP
Citation: Er. Arrowsmith et al., MEGA-THERAPY FOR HIGH-RISK AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) - THE VANDERBILT EXPERIENCE WITH HIGH-DOSE, BRIEF-DURATION CHEMOTHERAPY, Blood, 90(10), 1997, pp. 837-837
RECURRENT HODGKINS-DISEASE AFTER BONE-MARROW TRANSPLANTATION
Authors: SHAHAB I GREER JP BEEKER TA WOLFF SN COLLINS RD COUSAR JB
Citation: I. Shahab et al., RECURRENT HODGKINS-DISEASE AFTER BONE-MARROW TRANSPLANTATION, American journal of clinical pathology, 107(1), 1997, pp. 74-80
NOCARDIAL INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: CHOUCINO C GOODMAN SA GREER JP STEIN RS WOLFF SN DUMMER JS
Citation: C. Choucino et al., NOCARDIAL INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS, Clinical infectious diseases, 23(5), 1996, pp. 1012-1019
ETOPOSIDE AND MITOXANTRONE AS A 2ND CYCLE OF CONSOLIDATION THERAPY FOLLOWING HIGH-DOSE CYTOSINE-ARABINOSIDE AND DAUNORUBICIN IN PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA IN REMISSION - A PILOT-STUDY
Authors: STEIN RS GREER JP FLEXNER JM GOODMAN S WOLFF SN
Citation: Rs. Stein et al., ETOPOSIDE AND MITOXANTRONE AS A 2ND CYCLE OF CONSOLIDATION THERAPY FOLLOWING HIGH-DOSE CYTOSINE-ARABINOSIDE AND DAUNORUBICIN IN PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA IN REMISSION - A PILOT-STUDY, Leukemia & lymphoma, 23(1-2), 1996, pp. 93-98
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP
Authors: BROWN RA WOLFF SN FAY JW PINEIRO L COLLINS RH LYNCH JP STEVENS D GREER J HERZIG RH HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP, Leukemia & lymphoma, 22(3-4), 1996, pp. 271-277
KI-1-CELL LYMPHOMA (ALCL) - CORRELATION OF CLINICAL-FEATURES WITH P80(MPH( ANAPLASTIC LARGE)ALX) EXPRESSION AND HISTOLOGY/
Authors: GREER JP FLEXNER JM KALLIANPUR AR GOODMAN SA STEIN RS WHITLOCK JM WOLFF SN KINNEY MC
Citation: Jp. Greer et al., KI-1-CELL LYMPHOMA (ALCL) - CORRELATION OF CLINICAL-FEATURES WITH P80(MPH( ANAPLASTIC LARGE)ALX) EXPRESSION AND HISTOLOGY/, Blood, 88(10), 1996, pp. 886-886
MIS-MATCHED (MM) RELATED ALLOGENEIC (ALLO) BONE-MARROW TRANSPLANTATION (BMT) - ANALYSIS OF PROGNOSTIC FACTORS AND LONG-TERM SURVIVAL (LTS)
Authors: ARROWSMITH ER GOODMAN SA COLLINS RH WOOD S GREER JP EDWARDS J STEIN RS BRANDT SA PINEIRO LA STEIN B KALLIANPUR A FAY JW WOLFF SN
Citation: Er. Arrowsmith et al., MIS-MATCHED (MM) RELATED ALLOGENEIC (ALLO) BONE-MARROW TRANSPLANTATION (BMT) - ANALYSIS OF PROGNOSTIC FACTORS AND LONG-TERM SURVIVAL (LTS), Blood, 88(10), 1996, pp. 1045-1045
PHASE-III STUDY COMPARING TACROLIMUS (PROGRAF(R), FK506) WITH CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT)
Authors: RATANATHARATHORN V NASH RA DEVINE SM PRZEPIORKA D KLEIN JL WEISDORF DJ FAY JW NADEMANEE AP ANTIN JH KARANES C AVALOS BR CHRISTIANSEN NP VANDERJAGT RH HERZIG RH LITZOW MR WOLFF SN LONGO WR PETERSEN FB BUELL DN MAHER RM FITZSIMMONS WE WINGARD JR
Citation: V. Ratanatharathorn et al., PHASE-III STUDY COMPARING TACROLIMUS (PROGRAF(R), FK506) WITH CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 1826-1826
OVEREXPRESSION OF THE MAJOR VAULT TRANSPORTER PROTEIN LUNG-RESISTANCEPROTEIN PREDICTS TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA
Authors: LIST AF SPIER CS GROGAN TM JOHNSON C ROE DJ GREER JP WOLFF SN BROXTERMAN HJ SCHEFFER GL SCHEPER RJ DALTON WS
Citation: Af. List et al., OVEREXPRESSION OF THE MAJOR VAULT TRANSPORTER PROTEIN LUNG-RESISTANCEPROTEIN PREDICTS TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA, Blood, 87(6), 1996, pp. 2464-2469
SEROEPIDEMIOLOGY OF HELICOBACTER-PYLORI INFECTION IN HEART-TRANSPLANTRECIPIENTS
Authors: DUMMER JS PEREZPEREZ GI BREINIG MK LEE A WOLFF SN KORMOS R GRIFFITH BP BLASER MJ
Citation: Js. Dummer et al., SEROEPIDEMIOLOGY OF HELICOBACTER-PYLORI INFECTION IN HEART-TRANSPLANTRECIPIENTS, Clinical infectious diseases, 21(5), 1995, pp. 1303-1305
RINGED SIDEROBLASTS - A FREQUENT OBSERVATION AFTER BONE-MARROW TRANSPLANTATION
Authors: MACON WR THAM KT GREER JP WOLFF SN
Citation: Wr. Macon et al., RINGED SIDEROBLASTS - A FREQUENT OBSERVATION AFTER BONE-MARROW TRANSPLANTATION, Modern pathology, 8(7), 1995, pp. 782-785
T-CELL-RICH B-CELL LYMPHOMAS - DIAGNOSIS AND RESPONSE TO THERAPY OF 44 PATIENTS
Authors: GREER JP MACON WR LAMAR RE WOLFF SN STEIN RS FLEXNER JM COLLINS RD COUSAR JB
Citation: Jp. Greer et al., T-CELL-RICH B-CELL LYMPHOMAS - DIAGNOSIS AND RESPONSE TO THERAPY OF 44 PATIENTS, Journal of clinical oncology, 13(7), 1995, pp. 1742-1750
GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS FOR MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION - COMPARISON BETWEEN CYCLOSPORINE-METHOTREXATE AND CYCLOSPORINE-METHOTREXATE-METHYLPREDNISOLONE
Authors: LEELASIRI A GREER JP STEIN RS GOODMAN S BRANDT SA EDWARDS JR WOLFF SN
Citation: A. Leelasiri et al., GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS FOR MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION - COMPARISON BETWEEN CYCLOSPORINE-METHOTREXATE AND CYCLOSPORINE-METHOTREXATE-METHYLPREDNISOLONE, Bone marrow transplantation, 15(3), 1995, pp. 401-405
SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) THERAPY FOR LYMPHOMA - RESULTS OF A PHASE-III MULTICENTER STUDY
Authors: FAY JW FELSER JM ABBOUD C BORSON R FREYTES C HERZIG R HURD D JANAKIRAMAN N JANSEN J LAZARUS H LYNCH JP MANGAN KF SAEZ R STEVENS DA WOLFF SN YANOVICH S STIFF P
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) THERAPY FOR LYMPHOMA - RESULTS OF A PHASE-III MULTICENTER STUDY, Blood, 86(10), 1995, pp. 875-875
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICANMARROW TRANSPLANT GROUP
Authors: BROWN RA WOLFF SN FAY JW PINEIRO L COLLINS RH LYNCH JP STEVENS D GREER J HERZIG RH HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICANMARROW TRANSPLANT GROUP, Blood, 85(5), 1995, pp. 1391-1395
BONE-MARROW TRANSPLANTATION (BMT) FOR LEUKEMIA - 10-YEAR EXPERIENCE FAVORING EARLY ALLOGENEIC BMT
Authors: GREER JP KALLIANPUR AR GOODMAN SA EDWARDS JR STEIN RS BRANDT SJ WOLFF SN
Citation: Jp. Greer et al., BONE-MARROW TRANSPLANTATION (BMT) FOR LEUKEMIA - 10-YEAR EXPERIENCE FAVORING EARLY ALLOGENEIC BMT, Blood, 84(10), 1994, pp. 10000209-10000209
EFFECTIVE THERAPY FOR POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA WITH 8 WEEKS OF HIGH DOSE-INTENSITY COMBINATION CHEMOTHERAPY
Authors: WAITS TM GRECO FA GREER JP JOHNSON DH WOLFF SN STEIN RS MCMASTER ML HAINSWORTH JD
Citation: Tm. Waits et al., EFFECTIVE THERAPY FOR POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA WITH 8 WEEKS OF HIGH DOSE-INTENSITY COMBINATION CHEMOTHERAPY, Journal of clinical oncology, 11(5), 1993, pp. 943-949
SIMULTANEOUS AND SEQUENTIAL RHIL-3 (SDZ ILE 964) AND RHG-CSF (NEUPOGEN) POST AUTOLOGOUS BONE-MARROW TRANSPLANTATION NABMT) FOR LYMPHOMA - APHASE-I-II STUDY
Authors: WOLFF SN AHMED T VANBESIEN K SCHUSTER M CHAMPLIN R STEIN RS GREER JP DICESARE J FELSER J
Citation: Sn. Wolff et al., SIMULTANEOUS AND SEQUENTIAL RHIL-3 (SDZ ILE 964) AND RHG-CSF (NEUPOGEN) POST AUTOLOGOUS BONE-MARROW TRANSPLANTATION NABMT) FOR LYMPHOMA - APHASE-I-II STUDY, Blood, 82(10), 1993, pp. 10000287-10000287
GVHD PROPHYLAXIS FOR MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION (MUD) - COMPARISON BETWEEN CYCLOSPORINE-METHOTREXATE-METHYLPREDNISOLONE (CSA-MTX-MP) AND CSA-MTX
Authors: LEELASIRI A GREER JP STEIN RS GOODMAN S EDWARDS JR WOLFF SN
Citation: A. Leelasiri et al., GVHD PROPHYLAXIS FOR MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION (MUD) - COMPARISON BETWEEN CYCLOSPORINE-METHOTREXATE-METHYLPREDNISOLONE (CSA-MTX-MP) AND CSA-MTX, Blood, 82(10), 1993, pp. 10000420-10000420
Risultati: 1-25 | 26-27